301 related articles for article (PubMed ID: 24965368)
1. Prophylactic mastectomy: who needs it, when and why.
Burke EE; Portschy PR; Tuttle TM
J Surg Oncol; 2015 Jan; 111(1):91-5. PubMed ID: 24965368
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.
Chagpar AB
Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342
[TBL] [Abstract][Full Text] [Related]
3. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
[TBL] [Abstract][Full Text] [Related]
4. Contralateral prophylactic mastectomy: are we overtreating patients?
Burke EE; Portschy PR; Tuttle TM
Expert Rev Anticancer Ther; 2014 May; 14(5):491-4. PubMed ID: 24524287
[TBL] [Abstract][Full Text] [Related]
5. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.
Grimmer L; Liederbach E; Velasco J; Pesce C; Wang CH; Yao K
J Am Coll Surg; 2015 Jul; 221(1):187-96. PubMed ID: 26047763
[TBL] [Abstract][Full Text] [Related]
6. The increasing use of prophylactic mastectomy in the prevention of breast cancer.
Tuttle TM; Abbott A; Arrington A; Rueth N
Curr Oncol Rep; 2010 Jan; 12(1):16-21. PubMed ID: 20425603
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
[TBL] [Abstract][Full Text] [Related]
8. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
9. Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer.
Soran A; Ibrahim A; Kanbour M; McGuire K; Balci FL; Polat AK; Thomas C; Bonaventura M; Ahrendt G; Johnson R
Am J Clin Oncol; 2015 Apr; 38(2):179-83. PubMed ID: 23648435
[TBL] [Abstract][Full Text] [Related]
10. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
11. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis.
Silva AK; Lapin B; Yao KA; Song DH; Sisco M
Ann Surg Oncol; 2015 Oct; 22(11):3474-80. PubMed ID: 26001862
[TBL] [Abstract][Full Text] [Related]
13. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
14. When is contralateral mastectomy warranted in unilateral breast cancer?
Barry M; Sacchini V
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1209-14. PubMed ID: 21916574
[TBL] [Abstract][Full Text] [Related]
15. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
16. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Friebel TM; Domchek SM; Neuhausen SL; Wagner T; Evans DG; Isaacs C; Garber JE; Daly MB; Eeles R; Matloff E; Tomlinson G; Lynch HT; Tung N; Blum JL; Weitzel J; Rubinstein WS; Ganz PA; Couch F; Rebbeck TR
Clin Breast Cancer; 2007 Dec; 7(11):875-82. PubMed ID: 18269778
[TBL] [Abstract][Full Text] [Related]
17. The contralateral prophylactic mastectomy decision-making process.
Baker SK; Mayer DK; Esposito N
Plast Surg Nurs; 2013; 33(1):11-21; quiz 22-3. PubMed ID: 23446503
[TBL] [Abstract][Full Text] [Related]
18. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
[TBL] [Abstract][Full Text] [Related]
19. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
[TBL] [Abstract][Full Text] [Related]
20. Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience.
Unukovych D; Sandelin K; Wickman M; Arver B; Johansson H; Brandberg Y; Liljegren A
Acta Oncol; 2012 Sep; 51(7):934-41. PubMed ID: 22409595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]